Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
3.020
-0.020 (-0.66%)
At close: May 12, 2025, 4:00 PM
3.020
0.00 (0.00%)
After-hours: May 12, 2025, 4:53 PM EDT
Terns Pharmaceuticals Market Cap
Terns Pharmaceuticals has a market cap or net worth of $263.76 million as of May 12, 2025. Its market cap has decreased by -14.11% in one year.
Market Cap
263.76M
Enterprise Value
-66.65M
1-Year Change
-14.11%
Ranking
Category
Stock Price
$3.02
Market Cap Chart
Since the IPO on February 5, 2021, Terns Pharmaceuticals's market cap has increased from $143.61M to $263.76M, an increase of 83.66%. That is a compound annual growth rate of 15.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 265.51M | -43.58% |
| Dec 31, 2024 | 470.56M | 17.33% |
| Dec 29, 2023 | 401.05M | -20.44% |
| Dec 30, 2022 | 504.08M | 182.17% |
| Dec 31, 2021 | 178.64M | 24.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |